High-grade B-cell lymphoma (HGBCL)

Clinical trials for High-grade B-cell lymphoma (HGBCL) explained in plain language.

Never miss a new study

Get alerted when new High-grade B-cell lymphoma (HGBCL) trials appear

Sign up with your email to follow new studies for High-grade B-cell lymphoma (HGBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 2

Can a Macrophage-Targeting drug supercharge CAR-T therapy?

Disease control Not yet recruiting

This trial tests whether adding a drug called axatilimab to standard CAR-T cell therapy can improve outcomes for people with high-risk large B-cell lymphomas. Axatilimab works by conditioning macrophages, a type of immune cell, to potentially help the CAR-T cells fight cancer mor…

Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)

Phase 1 • Sponsor: Northside Hospital, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

High-grade B-cell lymphoma (HGBCL)

Get alerted when new High-grade B-cell lymphoma (HGBCL) trials appear

Can a Macrophage-Targeting drug supercharge CAR-T therapy?